Zobrazeno 1 - 10
of 477
pro vyhledávání: '"pulmonary sarcomatoid carcinoma"'
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1019-1024 (2024)
Introduction: Pulmonary sarcomatoid carcinomas (PSCs) are a rare subgroup of non-small cell lung cancer (NSCLC). In contrast to other NSCLCs, PSCs have a poor prognosis due to limited efficacy of radiation and chemotherapy. Therefore, other therapeut
Externí odkaz:
https://doaj.org/article/e9aeacf3b12541dba69d6d6178168d3b
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 7, Pp 514-522 (2024)
Background and objective Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small cell lung cancer (NSCLC), which is featured by low incidence, high malignancy rate, robust aggressive behavior and inferior prognosis. To date, there is no
Externí odkaz:
https://doaj.org/article/82b2cd646db54111b20c9346bcdfd32f
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundPulmonary sarcomatoid carcinoma (PSC) is a highly aggressive malignancy with a significant risk of recurrence even after surgical intervention, leading to a dismal prognosis. In recent years, perioperative immunotherapy has demonstrated pro
Externí odkaz:
https://doaj.org/article/eea8f036ec1a4050ac0303bebe4f5385
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Pulmonary sarcomatoid carcinoma (PSC), a rare non-small cell lung cancer (NSCLC) subtype, poses diagnostic and treatment difficulties. Current research explores targeted therapies and immunotherapy to improve patient outcomes. This case report detail
Externí odkaz:
https://doaj.org/article/8fdba06d955a46ffa3d8d99c4eb90fbd
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe tumor growth rate and tumor volume doubling time are crucial parameters in diagnosing and managing lung lesions. Pulmonary sarcomatoid carcinoma (PSC) is a unique and highly malignant subtype of lung cancer, with limited documentation o
Externí odkaz:
https://doaj.org/article/807e552edf784fd78b5e6a214c4252b2
Autor:
Yingzhi Zhao, Shaohua Xie, Haoqian Zheng, Kaixin Zhang, Xin Gao, Wenwu Liu, Wei Dai, Hongfan Yu, Qiuling Shi, Bin Hu, Qiang Li, Tianpeng Xie, Xing Wei
Publikováno v:
Surgical Case Reports, Vol 10, Iss 1, Pp 1-6 (2024)
Abstract Background Pulmonary sarcomatoid carcinoma (PSC) is a rare and highly malignant type of non-small cell lung cancer (NSCLC), for which the treatment of choice is surgery. For peripheral PSC growing outward and invading the chest wall, a compl
Externí odkaz:
https://doaj.org/article/6136fd28126644c0a0b6fef9cd3ba230
Publikováno v:
Chinese Journal of Lung Cancer, Vol 27, Iss 2, Pp 157-160 (2024)
Pulmonary sarcomatoid carcinoma (PSC) is a rare and highly malignant tumor, which includes the following five pathologic types: pleomorphic carcinoma, spindle cell carcinoma, giant cell carcinoma, carcinosarcoma and pulmonary blastoma. The onset of P
Externí odkaz:
https://doaj.org/article/cb0d9646ae94410f8e39322240a17961
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundPulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small-cell lung cancer (NSCLC), which is resistant to chemotherapy and radiotherapy with a poor prognosis. PSC is highly malignant and is prone to recurrence even after surgery.
Externí odkaz:
https://doaj.org/article/574541fc9b5944499ac742c36fc08a91
Autor:
Yishu Guo, Xianling Liu, Hao Tang, Zhenhua Qiu, Fang Ma, Ao’ran Hu, Chaoyuan Liu, Yapeng Wang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Pulmonary sarcomatoid carcinoma (PSC) represents a rare and highly aggressive variant of lung cancer, characterized by its recalcitrance to conventional therapeutic modalities and the attendant dismal prognosis it confers. Recent breakthroughs in imm
Externí odkaz:
https://doaj.org/article/a19f11d6c55c4128b6dc46f202851c62
Autor:
Kei Sonehara, Shuhei Nozawa, Yusuke Suzuki, Taisuke Araki, Masamichi Komatsu, Kazunari Tateishi, Masayuki Hanaoka
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 939-945 (2023)
Pulmonary spindle cell carcinoma is a subtype of pulmonary sarcomatoid carcinoma and a very rare tumor type with a poor prognosis. A few case reports have documented patients with pulmonary sarcomatoid carcinoma with anaplastic lymphoma kinase rearra
Externí odkaz:
https://doaj.org/article/10df2b21bccf4e508b48e51ede6a3312